Literature DB >> 18498970

Caution in the use of bromocriptine in peripartum cardiomyopathy.

James D Fett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498970     DOI: 10.1016/j.jacc.2008.02.054

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Indication for bromocriptine in peripartum cardiomyopathy.

Authors:  Frederic Mouquet; Nicolas Lamblin; Pascal de Groote
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

2.  Management of peripartum cardiomyopathy.

Authors:  Garrick C Stewart
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 3.  Peripartum cardiomyopathy: moving towards a more central role of genetics.

Authors:  Roberto Cemin; Rajesh Janardhanan; Luca Donazzan; Massimo Daves
Journal:  Curr Cardiol Rev       Date:  2013-08

Review 4.  Peripartum cardiomyopathy.

Authors:  Tc Okeke; Cct Ezenyeaku; Lc Ikeako
Journal:  Ann Med Health Sci Res       Date:  2013-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.